As of Jul 31
| +0.10 / +1.84%|
The 1 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 6.75, with a high estimate of 6.75 and a low estimate of 6.75. The median estimate represents a +21.84% increase from the last price of 5.54.
The current consensus among 1 polled investment analysts is to Hold stock in China Cord Blood Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.